Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40012670
Localisation
France
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
23/03/2023
Statut
Classification
1.5°C
Année cible
FY2030
Statut
Targets set
Classification
1.5°C
Année cible
FY2045
Overall Net-Zero Target Sanofi commits to reach net-zero GHG emissions across the value chain by FY2045 from a FY2019 base year. Near-Term Targets Sanofi commits to reduce absolute scope 1 and 2 GHG emissions 55% by FY2030 from a FY2019 base year*. Sanofi commits to increase annual sourcing of renewable electricity from 11% in FY2019 to 80% by FY2025 and 100% by FY2030. Sanofi also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, capital goods, fuel and energy related activities, upstream transportation and distribution, waste generated in operations, business travel and employee commuting 30% by FY2030 from a FY2019 base year. *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets Sanofi commits to reduce absolute scope 1 and 2 and scope 3 GHG emissions 90% by FY2045 from a FY2019 base year*. *The target boundary includes land-related emissions and removals from bioenergy feedstocks.
Statut
Targets setAnnée cible
FY2045
Statut
BA1.5 memberDate d'engagement
05/08/2021
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
FR0000120578
LEI
549300E9PC51EN656011
Source : Science Based Targets initiative | Données publiques